Simple Summary Chondrosarcomas develop chemoresistance to standard anticancer drugs, making it difficult to control unresectable or metastatic chondrosarcomas. To improve …
Doxorubicin is a commonly used anticancer agent that can cause debilitating and irreversible cardiac injury. The initiating mechanisms contributing to this side effect remain …
CP Wu, S Lusvarghi, JC Wang, SH Hsiao… - Molecular …, 2019 - ACS Publications
The frequent occurrence of multidrug resistance (MDR) conferred by the overexpression of ATP-binding cassette (ABC) transporters ABCB1 and ABCG2 in cancer cells remains a …
SM Stefan - Future Medicinal Chemistry, 2019 - Taylor & Francis
Several ABC transporters (eg, ABCB1, ABCB4, ABCC1–5, ABCC10, ABCG2 and ABCG4) are known to contribute to the phenomenon of cancer-related multidrug resistance (MDR)[1] …
The development of multidrug resistance (MDR) in cancer patients driven by the overexpression of ATP-binding cassette (ABC) transporter ABCB1 or ABCG2 in cancer cells …
The overexpression of the human ATP-binding cassette (ABC) drug transporter ABCB1 (P- glycoprotein, P-gp) or ABCG2 (breast cancer resistance protein, BCRP) in cancer cells often …
The development of multidrug resistance (MDR) in cancer patients, which is often associated with the overexpression of ABCB1 (MDR1, P-glycoprotein) in cancer cells …
L Porcelli, M Garofoli, R Di Fonte, L Fucci… - Scientific Reports, 2020 - nature.com
Standard chemotherapy for soft tissue sarcomas has shown limited efficacy. Here, we sought to evaluate whether β-adrenergic receptor (β-AR) signalling contributed to the …
CP Wu, YC Li, M Murakami, SH Hsiao, YC Lee… - International Journal of …, 2023 - mdpi.com
ATP-binding cassette transporters, including ABCB1 (P-glycoprotein) and ABCG2 (BCRP/MXR/ABCP), are pivotal in multidrug resistance (MDR) development in cancer …